Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike

September 4, 2016

Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.

epipen alternative
Mark Baum / Imprimis Pharmceuticals

Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.

"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.

"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."


feel good videoDogs Are Forced To Wear The Things They Steal — And It’s Hilarious

feel good storiesThe Father Who Never Left His Son Behind

feel good storiesHow A Silly 11-Second Song About Dr Pepper Changed Her Life Overnight

feel good storiesMan’s Best Friend: The Story Behind An Unforgettable Tomb In London

feel good storiesSenior Cat Labeled 'Sad And Scared' Finds Forever Home

feel good storiesShe Could Have Kept Walking. Instead, She Stopped And Saved A Life

feel good videoDonkey Opens Door, Then Waits Patiently To Be Let In For A Hug

feel good videoMan Takes A Bull To Starbucks For A Pup Cup

feel good videoHis Kids Wanted To Help With His Videos, So He Let Them Narrate — It’s The Cutest Thing

feel good video'You're a Unicorn': The Dementia Caregiver Who Just Stunned The American Idol Judges

feel good videoCat Steals The Spotlight By Singing Exactly Like His Owner